Susquehanna International Group, LLP Ac Immune Sa Transaction History
Susquehanna International Group, LLP
- $823 Billion
- Q3 2025
A detailed history of Susquehanna International Group, LLP transactions in Ac Immune Sa stock. As of the latest transaction made, Susquehanna International Group, LLP holds 21,840 shares of ACIU stock, worth $72,290. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,840Holding current value
$72,290% of portfolio
0.0%Shares
12 transactions
Others Institutions Holding ACIU
# of Institutions
43Shares Held
26.8MCall Options Held
94.9KPut Options Held
22.5K-
Bvf Inc San Francisco, CA19.8MShares$65.6 Million3.24% of portfolio
-
Black Rock Inc. New York, NY2.61MShares$8.63 Million0.0% of portfolio
-
Wells Fargo & Company San Francisco, CA1.01MShares$3.34 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny895KShares$2.96 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny770KShares$2.55 Million0.0% of portfolio
About AC Immune SA
- Ticker ACIU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,413,504
- Market Cap $276M
- Description
- AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...